204 related articles for article (PubMed ID: 9877110)
21. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
[TBL] [Abstract][Full Text] [Related]
22. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
[TBL] [Abstract][Full Text] [Related]
23. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
24. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
25. The role of cholecystectomy in acquired immunodeficiency syndrome.
Flum DR; Steinberg SD; Sarkis AY; Pacholka JR; Wallack MK
J Am Coll Surg; 1997 Mar; 184(3):233-9. PubMed ID: 9060917
[TBL] [Abstract][Full Text] [Related]
26. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
27. Frequency and associated factors of proteinuria in Iranian HIV-positive patients.
Ramezani A; Mohraz M; Banifazl M; Jam S; Gachkar L; Yaghmaie F; Eslamifar A; Zadsar M; Kalantar N; Nemati K; Haghighi M; Rezaie M; Aghakhani A
Int J Infect Dis; 2008 Sep; 12(5):490-4. PubMed ID: 18394943
[TBL] [Abstract][Full Text] [Related]
28. Time-dependence of survival predictions based on markers of HIV disease. Swiss HIV Cohort Study.
Perneger TV; Abrahamowicz M; Bartlett G; Yerly S
J Investig Med; 2000 May; 48(3):207-12. PubMed ID: 10822902
[TBL] [Abstract][Full Text] [Related]
29. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
31. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience of HIV/AIDS in a municipal hospital in Taiwan.
Wu YL; Chang CC; Chang HC; Yang CH; Liao ST
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):84-95. PubMed ID: 10592814
[TBL] [Abstract][Full Text] [Related]
33. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
35. Survival on chronic dialysis: 10 years' experience of a single Colombian center.
Enríquez J; Bastidas M; Mosquera M; Ceballos O; Bastidas B; Argote E; Salazar J; Delgado M
Adv Perit Dial; 2005; 21():164-7. PubMed ID: 16686311
[TBL] [Abstract][Full Text] [Related]
36. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
37. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy.
Berger JR; Levy RM; Flomenhoft D; Dobbs M
Ann Neurol; 1998 Sep; 44(3):341-9. PubMed ID: 9749600
[TBL] [Abstract][Full Text] [Related]
39. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy.
Winston JA; Burns GC; Klotman PE
Semin Nephrol; 1998 Jul; 18(4):373-7. PubMed ID: 9692350
[TBL] [Abstract][Full Text] [Related]
40. Predictors of survival in HIV-infected patients on hemodialysis.
Perinbasekar S; Brod-Miller C; Pal S; Mattana J
Am J Nephrol; 1996; 16(4):280-6. PubMed ID: 8739279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]